|
| |
Image Results
Loading...
Loading...
EMTRIVA Pages on BioPortfolio:
|
Increased HIV survival rates generate upcoming treatment challenges
... fixed-dose combination (FDC) of Gilead's two NRTIs, Viread (tenofovir) and Emtriva (emtricitabine) and the NNRTI Sustiva (efavirenz). ...
http://www.bioportfolio.com/news/datamonitor_88.htm...
|
BioPortfolio Biotechnology BioNews : live article
Emtriva(R) (emtricitabine) sales were $9.6 million for the second quarter of 2007, an increase of 11 percent from $8.7 million in the second quarter of 2006
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...
|
BioPortfolio - Triangle Pharmaceuticals Incorporated
Emtricitabine (FTC; Emtriva), a potent deoxycytidine nucleoside reverse... 21st February, 2004, Triangle Pharmaceuticals, Inc., Gilead Sciences, Inc., ...
http://www.bioportfolio.com/biocorporate/10338-Triangle_Phar...
|
BioPortfolio Biotechnology BioNews : live article
Elsewhere, Gilead Sciences GILD climbed $3.30 , or 5 percent, to $70.12 after the company reported positive test results from its Viread and Emtriva drugs ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...
|
BioPortfolio - Indepth Browse
... Empty Sella Syndrome | Empyema | Emsam | Emtricitabine | Emtriva | Emulsions | Enablex | Enalapril Maleate | Enalaprilat | Enamel Microabrasion | Enbrel ...
http://www.bioportfolio.com/indepth/search/E.htm...
|
BioPortfolio's Approved Drugs News by Tradename - E
EMTRIVA · E-MYCIN · ENABLEX · ENALAPRIL_MALEATE · ENALAPRILAT ...
http://www.bioportfolio.co.uk/approved_drugs/approved_drug_n...
| Results from other life science and pharmaceutical sites:
Emtriva
EMTRIVA safely and effectively. See full prescribing information .... EMTRIVA capsules, containing 200 mg of emtricitabine, are size 1 hard gelatin ...
http://www.gilead.com/pdf/emtriva_pi.pdf...
|
Emtriva (emtricitabine) Capsules and Oral Solution
12 Jul 2009 ... In some patients infected with HBV and treated with Emtriva, the exacerbations of hepatitis B were associated with liver decompensation and ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-...
|
Emtriva, a One - Press Releases: Gilead
Emtriva attacks HIV by inhibiting reverse transcriptase, the enzyme that copies HIV RNA into new viral DNA. By interfering with this process, ...
http://www.gilead.com/pr_1057164902...
|
FDA Approval of Emtriva for treating HIV
30 Apr 2009 ... The Food and Drug Administration (FDA) announced on Wednesday, July 2, 2003, the approval of Emtriva (FTC, emtricitabine), a new nucleoside ...
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocat...
|
Emtricitabine - Wikipedia, the free encyclopedia
Emtricitabine (FTC), with trade name Emtriva (formerly Coviracil), is a nucleoside reverse transcriptase inhibitor (NRTI) for the treatment of HIV
infection ...
http://en.wikipedia.org/wiki/Emtricitabine...
|
AIDSinfo - HIV/AIDS Drug Information - Emtricitabine
28 Sep 2005 ... Emtricitabine, also known as Emtriva or FTC, is a type of medicine called a nucleoside ... Emtriva Gilead Sciences Inc 333 Lakeside Dr ...
http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailNT.aspx?MenuI...
|
Products: Gilead
17 Dec 2004 ... Atripla, Truvada, Viread and Emtriva are not indicated for the treatment of chronic hepatitis B virus (HBV) infection and the safety and ...
http://www.gilead.com/products...
|
Atazanavir (Reyataz) and emtricitabine (Emtriva) for HIV infection.
Atazanavir (Reyataz) and emtricitabine (Emtriva) for HIV infection. [No authors listed]. PMID: 14603099 [PubMed - indexed for MEDLINE]. Mesh Terms: ...
http://www.ncbi.nlm.nih.gov/pubmed/14603099...
|
HIV Drug Emtriva™ Approved for Marketing - Press Releases: Gilead
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission has granted Marketing Authorisation for Emtriva™ (emtricitabine, ...
http://www.gilead.com/pr_1067371563...
|
FDA Safety Labeling Changes: Emtriva, FazaClo, Climara/Climara Pro
14 Sep 2005 ... The FDA has approved revisions to the safety labeling for emtricitabine capsules (Emtriva), clozapine orally disintegrating tablets ...
http://www.medscape.com/viewarticle/512797...
|
|
